Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study | Zendy

Seung Kak Shin | Zendy; JinWoo Lee | Zendy; Hannah Ra | Zendy; Oh Sang Kwon | Zendy; Jongbeom Shin | Zendy; YoungJoo Jin | Zendy; Sangheun Lee | Zendy; Ki Jun Han | Zendy; Young Nam Kim | Zendy; Tae Hun Kim | Zendy; Yun Soo Kim | Zendy; Ju Hyun Kim | Zendy

Open Access

Durability of Sustained Virologic Response and Improvement of Fibrosis Markers after Daclatasvir and Asunaprevir Treatment in Genotype 1b Hepatitis C Virus-Infected Patients: a Real Life and Multicenter Study

Author(s) -

Seung Kak Shin,

JinWoo Lee,

Hannah Ra,

Oh Sang Kwon,

Jongbeom Shin,

YoungJoo Jin,

Sangheun Lee,

Ki Jun Han,

Young Nam Kim,

Tae Hun Kim,

Yun Soo Kim,

Ju Hyun Kim

Publication year - 2019

Publication title -

journal of korean medical science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.743

H-Index - 66

eISSN - 1598-6357

pISSN - 1011-8934

DOI - 10.3346/jkms.2019.34.e264

Subject(s) - daclatasvir , medicine , gastroenterology , ns5a , hepatitis c virus , aspartate transaminase , hepatitis c , hepacivirus , immunology , ribavirin , virus , biology , alkaline phosphatase , biochemistry , enzyme

DCV/ASV treatment for HCV GT1b infected patients without RAS achieved high SVR rates and showed durable SVR. Cirrhotic patients who achieved SVR12 showed the improvement of liver function and fibrosis markers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research